Xiaowu Huang

机构：Sun Yat-sen University, Fudan University, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Ministry of Education · ORCID：0000-0002-9035-6056

发表论文 184 篇 · 总被引 8639 次 · h-index 41

代表论文

• China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition) (2025 · Liver Cancer · 被引 41)
• FGFR2 fusion/rearrangement analysis in intrahepatic cholangiocarcinoma using DNA/RNA-based NGS and FISH (2025 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 被引 9)
• First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study (2025 · Signal Transduction and Targeted Therapy · 被引 8)
• The intrahepatic bacterial metataxonomic signature of patients with hepatocellular carcinoma (2024 · Scientific Reports · 被引 7)
• Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 6)
• Phase I study of Ori-C101, an armored GPC3-directed CAR-T, in patients with advanced hepatocellular carcinoma (HCC). (2025 · Journal of Clinical Oncology · 被引 5)